Global Human Fibrinogen Concentrate Market Size Study, by Form, by End User, by Indication and Regional Forecasts 2022-2032

PUBLISHED: July 11, 2024

PAGES: 200 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Global Human Fibrinogen Concentrate Market is valued at approximately USD 910 million in 2023 and is anticipated to grow with a healthy growth rate of more than 10.76% over the forecast period 2024-2032. Human fibrinogen is extensively used in various surgical specialties, including cardiovascular, urological, pulmonary, wound management, orthopedic, ophthalmic, neurosurgery, plastic, and reconstructive, and dental surgeries, to reduce blood loss. It plays a crucial role in sealing tissues during surgery, reducing perioperative and postoperative complications by minimizing fluid and air leakage and preventing fistula formation. The unique physiological action of human fibrinogen results in a fibrin clot that the body's natural wound healing process fully degrades.

The Global Human Fibrinogen Concentrate Market is further propelled by rise in the elderly population prone to chronic diseases, and the increase in conditions such as heart attacks, strokes, tumors, and blockages in blood vessels, which lead to more surgeries, are significantly driving the market. Additionally, the rise in sports injuries and road accidents further boosts the demand for human fibrinogen products. Sports injuries and road accidents often result in severe trauma, such as fractures, lacerations, and internal injuries. These injuries frequently require surgical interventions to repair damaged tissues and organs. Human fibrinogen products, such as fibrin sealants or fibrin glues, are crucial in these surgeries for hemostasis and tissue sealing. However, stringent regulatory requirements for product approval and the high cost associated with fibrinogen concentrate therapy is going to impede the overall demand for the market during the forecast period 2024-2032.

Key regions considered for the Global Human Fibrinogen Concentrate Market study include North America, Europe, Asia Pacific, Latin America, and Rest of the World. In 2023, North America was the dominating among regional market in terms of revenue owing to factors such as high prevalence of chronic heart diseases, the presence of key players, robust healthcare infrastructure, and substantial healthcare expenditure across the region. The stringent regulatory framework in North America ensures the safety and efficacy of medical products, including fibrinogen concentrate. Compliance with these regulations enhances confidence among healthcare providers and patients regarding the use of these therapies in clinical settings. Furthermore, the market in Asia Pacific is anticipated to develop at the fastest rate over the forecast period 2024-2032.

Major market players included in this report are:

LFB Biopharmaceuticals
Takeda Pharmaceutical Company Limited
CSL Behring GmbH
Intas Pharmaceuticals Limited
Harbin Pacific Biopharmaceutical Co., Ltd.
Octapharma USA
Baxter International Inc.
BioRad
Shanghai RAAS Blood Products Co., Ltd.
Biotest AG

The detailed segments and sub-segment of the market are explained below:

By Form

Lyophilized
Powder
Liquid

By End User

Hospitals
Ambulatory Surgical Centers
Others

By Indication

Congenital Fibrinogen Deficiency
Surgical Procedures

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

Chapter 1. Global Human Fibrinogen Concentrate Market Executive Summary

1.1. Global Human Fibrinogen Concentrate Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Form
- 1.3.2. By End User
- 1.3.3. By Indication
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Human Fibrinogen Concentrate Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Human Fibrinogen Concentrate Market Dynamics

3.1. Market Drivers
- 3.1.1. Rise in Elderly Population
- 3.1.2. Increase in Chronic Diseases and Surgeries
- 3.1.3. Growth in Sports Injuries and Road Accidents
3.2. Market Challenges
- 3.2.1. Stringent Regulatory Requirements
- 3.2.2. High Cost of Fibrinogen Concentrate Therapy
3.3. Market Opportunities
- 3.3.1. Introduction of Novel Human Fibrinogen Products
- 3.3.2. Expansion in Emerging Markets
- 3.3.3. Technological Advancements in Healthcare

Chapter 4. Global Human Fibrinogen Concentrate Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Human Fibrinogen Concentrate Market Size & Forecasts by Form 2022-2032

5.1. Segment Dashboard
5.2. Global Human Fibrinogen Concentrate Market: Form Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 5.2.1. Lyophilized
- 5.2.2. Powder
- 5.2.3. Liquid

Chapter 6. Global Human Fibrinogen Concentrate Market Size & Forecasts by End User 2022-2032

6.1. Segment Dashboard
6.2. Global Human Fibrinogen Concentrate Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 6.2.1. Hospitals
- 6.2.2. Ambulatory Surgical Centers
- 6.2.3. Others

Chapter 7. Global Human Fibrinogen Concentrate Market Size & Forecasts by Indication 2022-2032

7.1. Segment Dashboard
7.2. Global Human Fibrinogen Concentrate Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 7.2.1. Congenital Fibrinogen Deficiency
- 7.2.2. Surgical Procedures

Chapter 8. Global Human Fibrinogen Concentrate Market Size & Forecasts by Region 2022-2032

8.1. North America Human Fibrinogen Concentrate Market
- 8.1.1. U.S. Human Fibrinogen Concentrate Market
  - 8.1.1.1. Form breakdown size & forecasts, 2022-2032
  - 8.1.1.2. End User breakdown size & forecasts, 2022-2032
  - 8.1.1.3. Indication breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Human Fibrinogen Concentrate Market
  - 8.1.2.1. Form breakdown size & forecasts, 2022-2032
  - 8.1.2.2. End User breakdown size & forecasts, 2022-2032
  - 8.1.2.3. Indication breakdown size & forecasts, 2022-2032
8.2. Europe Human Fibrinogen Concentrate Market
- 8.2.1. U.K. Human Fibrinogen Concentrate Market
  - 8.2.1.1. Form breakdown size & forecasts, 2022-2032
  - 8.2.1.2. End User breakdown size & forecasts, 2022-2032
  - 8.2.1.3. Indication breakdown size & forecasts, 2022-2032
- 8.2.2. Germany Human Fibrinogen Concentrate Market
  - 8.2.2.1. Form breakdown size & forecasts, 2022-2032
  - 8.2.2.2. End User breakdown size & forecasts, 2022-2032
  - 8.2.2.3. Indication breakdown size & forecasts, 2022-2032
- 8.2.3. France Human Fibrinogen Concentrate Market
  - 8.2.3.1. Form breakdown size & forecasts, 2022-2032
  - 8.2.3.2. End User breakdown size & forecasts, 2022-2032
  - 8.2.3.3. Indication breakdown size & forecasts, 2022-2032
- 8.2.4. Spain Human Fibrinogen Concentrate Market
  - 8.2.4.1. Form breakdown size & forecasts, 2022-2032
  - 8.2.4.2. End User breakdown size & forecasts, 2022-2032
  - 8.2.4.3. Indication breakdown size & forecasts, 2022-2032
- 8.2.5. Italy Human Fibrinogen Concentrate Market
  - 8.2.5.1. Form breakdown size & forecasts, 2022-2032
  - 8.2.5.2. End User breakdown size & forecasts, 2022-2032
  - 8.2.5.3. Indication breakdown size & forecasts, 2022-2032
- 8.2.6. Rest of Europe Human Fibrinogen Concentrate Market
  - 8.2.6.1. Form breakdown size & forecasts, 2022-2032
  - 8.2.6.2. End User breakdown size & forecasts, 2022-2032
  - 8.2.6.3. Indication breakdown size & forecasts, 2022-2032
8.3. Asia-Pacific Human Fibrinogen Concentrate Market
- 8.3.1. China Human Fibrinogen Concentrate Market
  - 8.3.1.1. Form breakdown size & forecasts, 2022-2032
  - 8.3.1.2. End User breakdown size & forecasts, 2022-2032
  - 8.3.1.3. Indication breakdown size & forecasts, 2022-2032
- 8.3.2. India Human Fibrinogen Concentrate Market
  - 8.3.2.1. Form breakdown size & forecasts, 2022-2032
  - 8.3.2.2. End User breakdown size & forecasts, 2022-2032
  - 8.3.2.3. Indication breakdown size & forecasts, 2022-2032
- 8.3.3. Japan Human Fibrinogen Concentrate Market
  - 8.3.3.1. Form breakdown size & forecasts, 2022-2032
  - 8.3.3.2. End User breakdown size & forecasts, 2022-2032
  - 8.3.3.3. Indication breakdown size & forecasts, 2022-2032
- 8.3.4. Australia Human Fibrinogen Concentrate Market
  - 8.3.4.1. Form breakdown size & forecasts, 2022-2032
  - 8.3.4.2. End User breakdown size & forecasts, 2022-2032
  - 8.3.4.3. Indication breakdown size & forecasts, 2022-2032
- 8.3.5. South Korea Human Fibrinogen Concentrate Market
  - 8.3.5.1. Form breakdown size & forecasts, 2022-2032
  - 8.3.5.2. End User breakdown size & forecasts, 2022-2032
  - 8.3.5.3. Indication breakdown size & forecasts, 2022-2032
- 8.3.6. Rest of Asia Pacific Human Fibrinogen Concentrate Market
  - 8.3.6.1. Form breakdown size & forecasts, 2022-2032
  - 8.3.6.2. End User breakdown size & forecasts, 2022-2032
  - 8.3.6.3. Indication breakdown size & forecasts, 2022-2032
8.4. Latin America Human Fibrinogen Concentrate Market
- 8.4.1. Brazil Human Fibrinogen Concentrate Market
  - 8.4.1.1. Form breakdown size & forecasts, 2022-2032
  - 8.4.1.2. End User breakdown size & forecasts, 2022-2032
  - 8.4.1.3. Indication breakdown size & forecasts, 2022-2032
- 8.4.2. Mexico Human Fibrinogen Concentrate Market
  - 8.4.2.1. Form breakdown size & forecasts, 2022-2032
  - 8.4.2.2. End User breakdown size & forecasts, 2022-2032
  - 8.4.2.3. Indication breakdown size & forecasts, 2022-2032
- 8.4.3. Rest of Latin America Human Fibrinogen Concentrate Market
  - 8.4.3.1. Form breakdown size & forecasts, 2022-2032
  - 8.4.3.2. End User breakdown size & forecasts, 2022-2032
  - 8.4.3.3. Indication breakdown size & forecasts, 2022-2032
8.5. Middle East & Africa Human Fibrinogen Concentrate Market
- 8.5.1. Saudi Arabia Human Fibrinogen Concentrate Market
  - 8.5.1.1. Form breakdown size & forecasts, 2022-2032
  - 8.5.1.2. End User breakdown size & forecasts, 2022-2032
  - 8.5.1.3. Indication breakdown size & forecasts, 2022-2032
- 8.5.2. South Africa Human Fibrinogen Concentrate Market
  - 8.5.2.1. Form breakdown size & forecasts, 2022-2032
  - 8.5.2.2. End User breakdown size & forecasts, 2022-2032
  - 8.5.2.3. Indication breakdown size & forecasts, 2022-2032
- 8.5.3. Rest of Middle East & Africa Human Fibrinogen Concentrate Market
  - 8.5.3.1. Form breakdown size & forecasts, 2022-2032
  - 8.5.3.2. End User breakdown size & forecasts, 2022-2032
  - 8.5.3.3. Indication breakdown size & forecasts, 2022-2032

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. LFB Biopharmaceuticals
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Takeda Pharmaceutical Company Limited
- 9.3.3. CSL Behring GmbH
- 9.3.4. Intas Pharmaceuticals Limited
- 9.3.5. Harbin Pacific Biopharmaceutical Co., Ltd.
- 9.3.6. Octapharma USA
- 9.3.7. Baxter International Inc.
- 9.3.8. BioRad
- 9.3.9. Shanghai RAAS Blood Products Co., Ltd.
- 9.3.10. Biotest AG

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes